(PharmaNewsWire.Com, January 06, 2018 ) North America CT Scan Market was worth $2.2 billion in 2016 and estimated to reach $2.73billion by the end of 2021 with a CAGR of 4.44%. CT Scan (Computed Tomography) is an imaging of the body that uses tomography and digital geometry to generate a 3D image of the internal organs of a body. The evolution of CT scanners has advanced to the point where the number of slices per rotation no longer is the benchmark for performance. With the advent of high-speed and multi-slice CT scanners, healthcare providers have changed their approach to imaging, diagnosis and treatment of patients as new ways for clinical applications in such areas as trauma, vascular, pediatric, and cardiac imaging are possible due to the higher speeds at which scanning can be done. CAD software has been pivotal in bringing new applications to CT, for example, making cancer detection possible with CT.
The multi-slice feature has evolved CT from simply a diagnostic tool into an interventional modality. The innovation cycle of CT has become indeed very short with new and cutting-edge technology is getting introduced in the market with each being more efficient and faster. There is an increasing demand for high slice CT. The high slice CT scan is expected to improve the clinical utility considerably, as the introduction of 256 slice scanner, which has a detector width of 10 to 12 cm would help in scanning organs, including brain, heart, entire joints, and lungs and liver, within a single rotation. It is also expected to have the feature to scan the heart with a single heartbeat.
Some of the main factors driving industry growth are rapidly growing demand for bedside imaging, home healthcare, and growing use of CT scan to assess the accuracy of post interventional medical procedures, medical implants and anatomical confirmation. Increasing prevalence of diseases such as cancer, orthopedic, cardiovascular and dental disorders will also enhance the growth of the market. Other drivers of growth include the growing demands from governments for premium healthcare delivery. Significant advances in imaging technologies promise to improve wellness through quicker and more precise detection of medical conditions. A rising fiscal deficit is expected to hinder the growth of CT Scan market. Also, CT imaging radiation dose continues to be an area of concern. A lot of patients and medical associations have raised this issue and raised their voice against the possible side-effects of CT scanning. The industry continues to try to reduce exposure while ensuring image quality.
Some of the major players in this market are GE Healthcare, Hitachi Medical Corporation, Hitachi Medical Systems America, Inc., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Philips Healthcare, Shenzhen Anke High-Tech Co., Siemens Healthcare, and Toshiba Medical Systems Corporation.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: